Cargando…

Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria

BACKGROUND: Patent medicine vendors (PMV) provide antimalarial treatment and care throughout Sub-Saharan Africa, and can play an important role in the fight against malaria. Their close-to-client infrastructure could enable lifesaving artemisinin-based combination therapy (ACT) to reach patients in...

Descripción completa

Detalles Bibliográficos
Autores principales: Berendes, Sima, Adeyemi, Olusegun, Oladele, Edward Adekola, Oresanya, Olusola Bukola, Okoh, Festus, Valadez, Joseph J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440361/
https://www.ncbi.nlm.nih.gov/pubmed/22984555
http://dx.doi.org/10.1371/journal.pone.0044775
_version_ 1782243144010563584
author Berendes, Sima
Adeyemi, Olusegun
Oladele, Edward Adekola
Oresanya, Olusola Bukola
Okoh, Festus
Valadez, Joseph J.
author_facet Berendes, Sima
Adeyemi, Olusegun
Oladele, Edward Adekola
Oresanya, Olusola Bukola
Okoh, Festus
Valadez, Joseph J.
author_sort Berendes, Sima
collection PubMed
description BACKGROUND: Patent medicine vendors (PMV) provide antimalarial treatment and care throughout Sub-Saharan Africa, and can play an important role in the fight against malaria. Their close-to-client infrastructure could enable lifesaving artemisinin-based combination therapy (ACT) to reach patients in time. However, systematic assessments of drug sellers’ performance quality are crucial if their role is to be managed within the health system. Lot quality assurance sampling (LQAS) could be an efficient method to monitor and evaluate PMV practice, but has so far never been used for this purpose. METHODS: In support of the Nigeria Malaria Booster Program we assessed PMV practices in three Senatorial Districts (SDs) of Jigawa, Nigeria. A two-stage LQAS assessed whether at least 80% of PMV stores in SDs used national treatment guidelines. Acceptable sampling errors were set in consultation with government officials (alpha and beta <0.10). The hypergeometric formula determined sample sizes and cut-off values for SDs. A structured assessment tool identified high and low performing SDs for quality of care indicators. FINDINGS: Drug vendors performed poorly in all SDs of Jigawa for all indicators. For example, all SDs failed for stocking and selling first-line antimalarials. PMV sold no longer recommended antimalarials, such as Chloroquine, Sulfadoxine-Pyrimethamine and oral Artesunate monotherapy. Most PMV were ignorant of and lacked training about new treatment guidelines that had endorsed ACTs as first-line treatment for uncomplicated malaria. CONCLUSION: There is urgent need to regularly monitor and improve the availability and quality of malaria treatment provided by medicine sellers in Nigeria; the irrational use of antimalarials in the ACT era revealed in this study bears a high risk of economic loss, death and development of drug resistance. LQAS has been shown to be a suitable method for monitoring malaria-related indicators among PMV, and should be applied in Nigeria and elsewhere to improve service delivery.
format Online
Article
Text
id pubmed-3440361
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34403612012-09-14 Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria Berendes, Sima Adeyemi, Olusegun Oladele, Edward Adekola Oresanya, Olusola Bukola Okoh, Festus Valadez, Joseph J. PLoS One Research Article BACKGROUND: Patent medicine vendors (PMV) provide antimalarial treatment and care throughout Sub-Saharan Africa, and can play an important role in the fight against malaria. Their close-to-client infrastructure could enable lifesaving artemisinin-based combination therapy (ACT) to reach patients in time. However, systematic assessments of drug sellers’ performance quality are crucial if their role is to be managed within the health system. Lot quality assurance sampling (LQAS) could be an efficient method to monitor and evaluate PMV practice, but has so far never been used for this purpose. METHODS: In support of the Nigeria Malaria Booster Program we assessed PMV practices in three Senatorial Districts (SDs) of Jigawa, Nigeria. A two-stage LQAS assessed whether at least 80% of PMV stores in SDs used national treatment guidelines. Acceptable sampling errors were set in consultation with government officials (alpha and beta <0.10). The hypergeometric formula determined sample sizes and cut-off values for SDs. A structured assessment tool identified high and low performing SDs for quality of care indicators. FINDINGS: Drug vendors performed poorly in all SDs of Jigawa for all indicators. For example, all SDs failed for stocking and selling first-line antimalarials. PMV sold no longer recommended antimalarials, such as Chloroquine, Sulfadoxine-Pyrimethamine and oral Artesunate monotherapy. Most PMV were ignorant of and lacked training about new treatment guidelines that had endorsed ACTs as first-line treatment for uncomplicated malaria. CONCLUSION: There is urgent need to regularly monitor and improve the availability and quality of malaria treatment provided by medicine sellers in Nigeria; the irrational use of antimalarials in the ACT era revealed in this study bears a high risk of economic loss, death and development of drug resistance. LQAS has been shown to be a suitable method for monitoring malaria-related indicators among PMV, and should be applied in Nigeria and elsewhere to improve service delivery. Public Library of Science 2012-09-12 /pmc/articles/PMC3440361/ /pubmed/22984555 http://dx.doi.org/10.1371/journal.pone.0044775 Text en © 2012 Berendes et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Berendes, Sima
Adeyemi, Olusegun
Oladele, Edward Adekola
Oresanya, Olusola Bukola
Okoh, Festus
Valadez, Joseph J.
Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria
title Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria
title_full Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria
title_fullStr Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria
title_full_unstemmed Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria
title_short Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria
title_sort are patent medicine vendors effective agents in malaria control? using lot quality assurance sampling to assess quality of practice in jigawa, nigeria
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440361/
https://www.ncbi.nlm.nih.gov/pubmed/22984555
http://dx.doi.org/10.1371/journal.pone.0044775
work_keys_str_mv AT berendessima arepatentmedicinevendorseffectiveagentsinmalariacontrolusinglotqualityassurancesamplingtoassessqualityofpracticeinjigawanigeria
AT adeyemiolusegun arepatentmedicinevendorseffectiveagentsinmalariacontrolusinglotqualityassurancesamplingtoassessqualityofpracticeinjigawanigeria
AT oladeleedwardadekola arepatentmedicinevendorseffectiveagentsinmalariacontrolusinglotqualityassurancesamplingtoassessqualityofpracticeinjigawanigeria
AT oresanyaolusolabukola arepatentmedicinevendorseffectiveagentsinmalariacontrolusinglotqualityassurancesamplingtoassessqualityofpracticeinjigawanigeria
AT okohfestus arepatentmedicinevendorseffectiveagentsinmalariacontrolusinglotqualityassurancesamplingtoassessqualityofpracticeinjigawanigeria
AT valadezjosephj arepatentmedicinevendorseffectiveagentsinmalariacontrolusinglotqualityassurancesamplingtoassessqualityofpracticeinjigawanigeria